OpenLB
Open Library of Bioscience

Selection between sunitinib and ripretinib using mutation analysis for gastrointestinal stromal tumor patients progressing on imatinib.

Abstract

No abstract text available.

Keywords

References

1. Eur J Cancer. 2021 Mar;145:132-142 [PMID: 33465704]
2. Nat Med. 2024 Feb;30(2):498-506 [PMID: 38182785]
3. J Clin Oncol. 2008 Nov 20;26(33):5352-9 [PMID: 18955458]
4. Lancet Oncol. 2020 Jul;21(7):923-934 [PMID: 32511981]
5. Nat Rev Clin Oncol. 2022 May;19(5):328-341 [PMID: 35217782]
6. J Clin Oncol. 2006 Oct 10;24(29):4764-74 [PMID: 16954519]
7. J Clin Oncol. 2008 Feb 1;26(4):620-5 [PMID: 18235121]
8. Cancer Epidemiol. 2016 Feb;40:39-46 [PMID: 26618334]
9. Cancer Cell. 2019 May 13;35(5):738-751.e9 [PMID: 31085175]
10. J Clin Oncol. 2015 Feb 20;33(6):634-42 [PMID: 25605837]
11. Eur J Cancer. 2023 Oct;192:113245 [PMID: 37598656]
12. J Clin Oncol. 2012 Apr 20;30(12):1371-7 [PMID: 22430274]
13. Eur J Cancer. 2006 May;42(8):1093-103 [PMID: 16624552]
14. J Pathol. 2008 Sep;216(1):64-74 [PMID: 18623623]
15. Lancet. 2006 Oct 14;368(9544):1329-38 [PMID: 17046465]
16. J Clin Oncol. 2022 Dec 1;40(34):3918-3928 [PMID: 35947817]
17. Am J Clin Oncol. 2020 Apr;43(4):270-278 [PMID: 31904710]
18. Clin Cancer Res. 2006 Apr 15;12(8):2622-7 [PMID: 16638875]
19. Transl Cancer Res. 2021 Jul;10(7):3206-3217 [PMID: 35116627]
20. Eur J Cancer. 2009 Jul;45(11):1959-68 [PMID: 19282169]
21. J Clin Oncol. 2017 May 20;35(15):1713-1720 [PMID: 28362562]
22. N Engl J Med. 2002 Aug 15;347(7):472-80 [PMID: 12181401]